As positive controls for this analysis, we analyzed two CRC-associated recurrent fusions, PTPRK-RSPO3 and TPM3-NTRK1, in three of our patient samples (Fig. 3A)27,29. This evidence concerns the gene PTPRK and colorectal carcinoma.